Literature DB >> 23483097

Radiofrequency ablation during continuous saline infusion can extend ablation margins.

Toru Ishikawa1, Tomoyuki Kubota, Ryoko Horigome, Naruhiro Kimura, Hiroki Honda, Akito Iwanaga, Keiichi Seki, Terasu Honma, Toshiaki Yoshida.   

Abstract

AIM: To determine whether fluid injection during radiofrequency ablation (RFA) can increase the coagulation area.
METHODS: Bovine liver (1-2 kg) was placed on an aluminum tray with a return electrode affixed to the base, and the liver was punctured by an expandable electrode. During RFA, 5% glucose; 50% glucose; or saline fluid was infused continuously at a rate of 1.0 mL/min through the infusion line connected to the infusion port. The area and volume of the thermocoagulated region of bovine liver were determined after RFA. The Joule heat generated was determined from the temporal change in output during the RFA experiment.
RESULTS: No liquid infusion was 17.3 ± 1.6 mL, similar to the volume of a 3-cm diameter sphere (14.1 mL). Mean thermocoagulated volume was significantly larger with continuous infusion of saline (29.3 ± 3.3 mL) than with 5% glucose (21.4 ± 2.2 mL), 50% glucose (16.5 ± 0.9 mL) or no liquid infusion (17.3 ± 1.6 mL). The ablated volume for RFA with saline was approximately 1.7-times greater than for RFA with no liquid infusion, representing a significant difference between these two conditions. Total Joule heat generated during RFA was highest with saline, and lowest with 50% glucose.
CONCLUSION: RFA with continuous saline infusion achieves a large ablation zone, and may help inhibit local recurrence by obtaining sufficient ablation margins. RFA during continuous saline infusion can extend ablation margins, and may be prevent local recurrence.

Entities:  

Keywords:  Ex vivo bovine liver; Glucose; Joule heat; Large ablation zone; Radiofrequency ablation; Saline

Mesh:

Substances:

Year:  2013        PMID: 23483097      PMCID: PMC3587485          DOI: 10.3748/wjg.v19.i8.1278

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

Review 1.  Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance.

Authors:  S N Goldberg; G S Gazelle; P R Mueller
Journal:  AJR Am J Roentgenol       Date:  2000-02       Impact factor: 3.959

Review 2.  Treatment of hepatocellular carcinoma by interventional methods.

Authors:  T Livraghi
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

3.  Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect.

Authors:  David S K Lu; Steven S Raman; Darko J Vodopich; Michael Wang; James Sayre; Charles Lassman
Journal:  AJR Am J Roentgenol       Date:  2002-01       Impact factor: 3.959

4.  Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems.

Authors:  Alban L Denys; Thierry De Baere; Viseth Kuoch; Benoit Dupas; Patrick Chevallier; David C Madoff; Pierre Schnyder; Francesco Doenz
Journal:  Eur Radiol       Date:  2003-08-27       Impact factor: 5.315

Review 5.  Technologies for ablation of hepatocellular carcinoma.

Authors:  Matthew R Callstrom; J William Charboneau
Journal:  Gastroenterology       Date:  2008-05-16       Impact factor: 22.682

6.  Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin.

Authors:  Takahide Nakazawa; Shigehiro Kokubu; Akitaka Shibuya; Koji Ono; Masaaki Watanabe; Hisashi Hidaka; Takeshi Tsuchihashi; Katsunori Saigenji
Journal:  AJR Am J Roentgenol       Date:  2007-02       Impact factor: 3.959

7.  Percutaneous ultrasound-guided radiofrequency electrocautery ablation of prostate tissue in dogs.

Authors:  J P McGahan; S M Griffey; R W Budenz; J M Brock
Journal:  Acad Radiol       Date:  1995-01       Impact factor: 3.173

8.  Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients.

Authors:  L Solbiati; T Ierace; S N Goldberg; S Sironi; T Livraghi; R Fiocca; G Servadio; G Rizzatto; P R Mueller; A Del Maschio; G S Gazelle
Journal:  Radiology       Date:  1997-01       Impact factor: 11.105

9.  Radiofrequency ablation of liver tumors: Actual limitations and potential solutions in the future.

Authors:  Beat M Künzli; Paolo Abitabile; Christoph A Maurer
Journal:  World J Hepatol       Date:  2011-01-27

10.  Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma.

Authors:  Takashi Himoto; Kazutaka Kurokohchi; Seishiro Watanabe; Tsutomu Masaki
Journal:  Hepat Mon       Date:  2012-10-10       Impact factor: 0.660

View more
  1 in total

1.  Computed tomography guided radio-frequency ablation of osteoid osteomas in atypical locations.

Authors:  Julie Senne; Ryan Davis; Junaid Yasin; Olubusola Brimmo; Andrea Evenski; Ambarish P Bhat
Journal:  Indian J Radiol Imaging       Date:  2019-10-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.